Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/23/24 | Initial statement of beneficial ownership of securities |
|
1 | ||
| 08/23/24 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | ||
| 08/09/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/08/24 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
50 | |
| 08/07/24 | Current report filing |
|
|
8 | |
| 06/21/24 | SEC-generated letter |
|
1 | ||
| 06/14/24 | Registration statement for specified transactions by certain issuers |
|
46 | ||
| 05/15/24 | Current report filing |
|
|
4 | |
| 05/15/24 | Current report filing |
|
|
3 | |
| 05/14/24 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
49 |